ANTITUMORANTWORT AUF MODIFIZIERTE SELBSTEPITOPE

Patent europeic · EP3301447 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3301447
Numer da la dumonda
EP17194252
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
07-08-2013
Publitgà
04-04-2018
Concedì
02-12-2020
Stritgà
23-02-2022
Motiv
Taxa annuala betg pajada
Classas IPC
G01N 33/574 (2006.01)
A61K 39/00 (2006.01)
Prioritad
GB 201214007 07.08.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-03-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.03.2022

  2. 13-10-2021

    Midada

    Published in Swissreg on 13.10.2021

  3. 02-12-2020

    Concedì

    Published in Swissreg on 02.12.2020

Partidas

Possessur

Scancell Limited

City Hospital Hucknall Road, Nottingham NG5 1PB, GB

Inventur

DURRANT, Linda Gillian

Nottingham, NG5 1PB, GB

METHERINGHAM, Rachel Louise

Nottingham, NG5 1PB, GB

BRENTVILLE, Victoria Anne

Nottingham, NG5 1PB, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.